Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report

BACKGROUND: Waldenström’s macroglobulinemia is a rare B-cell lymphoma. The gold standard treatment for Waldenström’s macroglobulinemia is an anti-CD20 antibody (rituximab) in combination with alkylating agents and dexamethasone. Treatment targeting the B-cell receptor such as ibrutinib (but not idel...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Aveni-Piney, M., Divoux, M., Busby-Venner, H., Muller, M., Broséus, J., Feugier, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996512/
https://www.ncbi.nlm.nih.gov/pubmed/29890999
http://dx.doi.org/10.1186/s13256-018-1694-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996512/
https://www.ncbi.nlm.nih.gov/pubmed/29890999
http://dx.doi.org/10.1186/s13256-018-1694-z

Ejemplares similares